FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

1020311000001106: Methyldopa 125mg tablets 250 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22053301000001116 Methyldopa 125mg tablets 250 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22053401000001112 Methyldopa 125mg tablets 250 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Methyldopa 125mg tablets 250 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Methyldopa 125mg tablets 250 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Methyldopa 125mg tablets 250 tablet Is pack of Product containing precisely methyldopa 125 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Methyldopa 125mg tablets 250 tablet Has active ingredient Methyldopa false Inferred relationship Existential restriction modifier
Methyldopa 125mg tablets 250 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Methyldopa 125mg tablets 250 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Methyldopa 125mg tablets 250 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Methyldopa 125mg tablets 250 tablet Has VMP Product containing precisely methyldopa 125 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Methyldopa 125mg tablets 250 tablet Has specific active ingredient Methyldopa true Inferred relationship Existential restriction modifier
Methyldopa 125mg tablets 250 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Methyldopa 125mg tablets (Unichem Plc) 250 tablet Is a True Methyldopa 125mg tablets 250 tablet Inferred relationship Existential restriction modifier
Methyldopa 125mg tablets (Viatris UK Healthcare Ltd) 250 tablet Is a True Methyldopa 125mg tablets 250 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start